Invion Ltd News

Invion Ltd: Agreement with Major South Korean Pharma Group Hanlim

May 7 19:16 ET

Invion Ltd: Activities Report and Appendix 4C

Apr 29 23:12 ET

Invion Ltd: INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC

Mar 4 00:06 ET

Invion Ltd: Agreement with Dr.inB to develop Photosoft treatment for HPV

Feb 22 17:04 ET

Invion Ltd: Activities Report and Appendix 4C

Jan 29 16:55 ET

Invion Ltd: Change of Director's Interest Notice- Robert Merriel

Jan 18 17:22 ET

Invion Ltd: Change of Auditor

Jan 15 17:55 ET

Invion Ltd: Major Milestone towards Clinical Trials

Nov 20, 2023 22:13 ET

Invion Ltd: Activities Report and Appendix 4C

Oct 23, 2023 17:17 ET

Invion Ltd: Appendix 4G and Corporate Governance Statement

Sep 28, 2023 01:50 ET

Invion Ltd: Photosoft Territory Expanded to South Korea for Cancer

Sep 24, 2023 18:56 ET

Invion Ltd: Activities Report and Appendix 4C

Jul 19, 2023 19:26 ET

Invion Ltd: New Australian Patent Granted

Jul 4, 2023 18:45 ET

Invion Ltd: Change of Director's Interest Notice- Robert Merriel

May 2, 2023 02:45 ET

Invion Ltd: Activities Report and Appendix 4C

Apr 27, 2023 19:10 ET

Invion Ltd: Invion launches Interactive Investor Hub

Apr 10, 2023 18:54 ET

Invion Ltd: Change of Director's Interest Notice- Alan Yamashita

Feb 12, 2023 17:33 ET

Invion Ltd: Change of Director's Interest Notice - Thian Chew

Feb 12, 2023 17:31 ET

Invion Ltd: Expansion of Territory Rights to USA, Canada and Hong Kong

Feb 7, 2023 16:24 ET

Invion Ltd: Activities Report and Appendix 4C

Jan 29, 2023 16:41 ET